We are live on ! Find out more
ENZ icon

Enzo Biochem

Delisted

ENZ was delisted on the 17th of April, 2025.

100 hedge funds and large institutions have $101M invested in Enzo Biochem in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 30 increasing their positions, 24 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 9

60% more call options, than puts

Call options by funds: $481K | Put options by funds: $300K

25% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 24

12% more funds holding

Funds holding: 89 → 100 (+11)

9% more capital inflows, than outflows

Capital inflows: $11.5M | Capital outflows: $10.5M

0.58% more ownership

Funds ownership: 47.57% → 48.15% (+0.58%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
100
Holders Change
+11
Holders Change %
+12.36%
% of All Funds
2.65%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
19
Increased
30
Reduced
24
Closed
9
Calls
$481​K
Puts
$300​K
Net Calls
+$181​K
Net Calls Change
+$179​K

ENZ Hedge Fund Activity: Q1 2016 in Review

100 of the 3,768 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem (ENZ) for Q1 2016, worth a combined $101M — up 2.2% from $98.6M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ENZ positions and 9 closed out — a net gain of 10 holders — while 30 added to existing stakes and 24 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $3.47M. The largest seller was First Light Asset Management, cutting an estimated $2.48M.

  • 100 institutional investors held Enzo Biochem (ENZ) as of Q1 2016, up from 89 in Q4 2015.
  • Funds reported $101M of Enzo Biochem stock for Q1 2016, up 2.2% quarter-over-quarter.
  • 19 funds opened new Enzo Biochem positions in Q1 2016 and 9 closed out, a net change of +10 holders.
  • The largest Enzo Biochem buyer in Q1 2016 was Acadian Asset Management, an estimated $3.47M added.
  • The largest Enzo Biochem seller in Q1 2016 was First Light Asset Management, an estimated $2.48M sold.

Based on aggregated 13F filings for Q1 2016.